Comparison of demographics and percentage with known HIV-associated cancer cases between those with HIV(+) serology and those who met clinical criteria only.

<p>[<u>Notes</u>: *Statistically significant difference (p = 0.005) between positive serology group (n = 47) and clinical criteria only group (n = 124) with respect to the patient characteristic (Chi-square test)].</p

Level of strength-of-evidence of HIV infection/AIDS in 171 cancer cases that were registered.

<p>Of the subsequent confirmed HIV(+) serology 12 were identified at the Comprehensive Care Clinic and 10 at the Department of Radiation Oncology at Kenyatta National Hospital. [<u>Notes</u>: *Statistically significant difference (p = 0.022) between positive serology group (n = 47) and clinical criteria only group (n = 124) with respect to the level strength-of-evidence (Chi-square test)].</p

Tumor types of 171 cancer cases with hierarchal association of HIV infection/AIDS.

<p>Of these total cases, 118 (69%) had demonstrable HIV association (i.e., KS, cervix, NHL, conjunctiva and Hodgkin’s disease) and the remaining 53 would be considered non-AIDS-defining cancer. [<u>Notes</u>: <b><i>Bold italics</i></b> – known HIV-associated malignancy; NOS – not otherwise specified].</p

Nairobi Cancer Registry (NCR) – reporting entities comprising this cancer population-based registry utilized for this study number of cases that met strength-of-evidence criteria for cancer-AIDS (HIV infection) match.

<p>Nairobi Cancer Registry (NCR) – reporting entities comprising this cancer population-based registry utilized for this study number of cases that met strength-of-evidence criteria for cancer-AIDS (HIV infection) match.</p